Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis

Pathology and Oncology Research

Volumn 13, Issue 4, 2007, Pages 336-339

  Croci, Stefania ^a   Landuzzi, Lorena ^b   Nicoletti, Giordano ^b   Palladini, Arianna ^a   Antognoli, Agnese ^a   De Giovanni, Carla ^a   Nanni, Patrizia ^a   Lollini, Pier Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

CCN proteins; CCN2 CTGF; Mouse model; Rhabdomyosarcoma

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; IN VITRO STUDY; MOUSE; MYOBLAST; NONHUMAN; ONCOGENE NEU; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 39649093392     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02940313     Document Type: Article

References (12)

1. Aikawa T, Gunn J, Spong SM et al: Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther 5: 1108-1116, 2006
2. Brigstock DR: The CCN family: a new stimulus package. J Endocrinol 178: 169-175, 2003
3. Croci S, Landuzzi L, Astolfi A et al: Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 64: 1730-1736, 2004
4. Dornhofer N, Spong S, Bennewith K et al: Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 66: 5816-5827, 2006
5. Lin BR, Chang CC, Che TF et al: Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 128: 9-23, 2005
6. Nanni P, Nicoletti G, De Giovanni C et al: Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res 63: 2728-2732, 2003
7. Palladini A, Astolfi A, Croci S et al: Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role. Eur J Cancer 42: 680-687, 2006
8. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 363: 62-64, 2004
9. Planque N, Perbal B: A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 3: 15, 2003
10. Shimo T, Kubota S, Yoshioka N et al: Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 21: 1045-1059, 2006
11. Yang DH, Kim HS, Wilson EM et al: Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab 83: 2593-2596, 1998
12. Yang F, Tuxhorn JA, Ressler SJ et al: Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895, 2005